Adherence behaviour with psychotropic medication is a form of self-medication

Medical Hypotheses

Volumn 68, Issue 1, 2007, Pages 12-21

  Mitchell, Alex J ^a  

^a LEICESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; CARBAMAZEPINE; CLOZAPINE; HALOPERIDOL; LITHIUM; MOOD STABILIZER; NEUROLEPTIC AGENT; TRICYCLIC ANTIDEPRESSANT AGENT; VALPROATE SEMISODIUM; VALPROIC ACID;

ARTICLE; BEHAVIOR; BIPOLAR DISORDER; CLINICAL TRIAL; COGNITION; COGNITIVE DEFECT; DEPRESSION; DISEASE SEVERITY; DOCTOR PATIENT RELATION; DRUG HYPERSENSITIVITY; DRUG PREFERENCE; DYSKINESIA; EXTRAPYRAMIDAL SYMPTOM; HEALTH BELIEF; HEALTH SURVEY; HUMAN; HYPOTHESIS; ILLNESS BEHAVIOR; INTROSPECTION; MEDICAL CARE; MEDICAL DECISION MAKING; MEDICAL INFORMATION; MENTAL DISEASE; METABOLIC DISORDER; MOTOR DYSFUNCTION; OBESITY; PALLIATIVE THERAPY; PATIENT ATTITUDE; PATIENT AUTONOMY; PATIENT COMPLIANCE; PERSISTENT VEGETATIVE STATE; PHYSICIAN; PREDICTOR VARIABLE; PRESCRIPTION; PRIORITY JOURNAL; PSYCHOMOTOR DISORDER; SCHIZOPHRENIA; SEDATION; SELF EVALUATION; SELF MEDICATION; SEXUAL DYSFUNCTION; SIDE EFFECT; UNSPECIFIED SIDE EFFECT; WEIGHT GAIN;

EID: 33750629015     PISSN: 03069877     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mehy.2006.07.005     Document Type: Article

References (119)

1. Osterberg L., and Blaschke T. Drug therapy adherence to medication. N Engl J Med 353 (2005) 487-497
2. Dunbar J. Adherence to medical advice: a review. Int. J. Ment. Health 9 (1980) 70-87
3. Gentili P., Maldonato A., Grieco R., and Santini A. Influence of patients' representations and beliefs about diabetes and its treatment on their adherence to therapy. Diabetes Nutr Metab 14 3 (2001) 140-152
4. Kardas P. Patient compliance with antibiotic treatment for respiratory tract infections. J Antimicrob Chemother 49 6 (2002) 897-903
5. Kardas P., and Ratajczyk-Pakalska E. Patient adherence in respiratory tract infections: ceftibuten versus other antibiotics (PARTICULAR study). Pol Merkuriusz Lek 10 (2001) 445
6. Cheung R., Sullens C.M., Seal D., Dickins J., Nicholson P.W., Deshmukh A.A., et al. The paradox of using a 7 day antibacterial course to treat urinary tract infections in the community. Br J Clin Pharmacol 26 (1988) 391-398
7. Barber N., Parsons J., Clifford S., Darracott R., and Horne R. Patients' problems with new medication for chronic Patients' conditions. Qual Saf Health Care 13 (2004) 172-175
8. Willcox Drc., Gillan R., and Hare E.H. Do psychiatric out-patients take their drugs. Br Med J 2 5465 (1965) 790
9. Cramer J.A., and Rosenheck R. Compliance with medication regimens for mental and physical disorders. Psychiatr Serv 49 (1998) 196-201
10. Whitney Jr HAK, et al., editors. Medication compliance: a healthcare problem. Ann Pharmacother 1993;27(Suppl. 9).
11. Mitchell A.J. High medication discontinuation rates in psychiatry - how often is it understandable?. J Clin Psychopharmacol 26 2 (2006) 109-112
12. Harris K.M., and Edlund M.J. Self-medication of mental health problems: new evidence from a national survey. Health Serv Res 40 1 (2005) 117-134
13. van Rijswijk E., van de Lisdonk E.H., and Zitman F.G. Who uses over-the-counter psychotropics? Characteristics, functioning, and (mental) health profile. Gen Hosp Psychiatry 22 4 (2000) 236-241
14. Rashid A. Do patients cash their prescriptions. Br Med J 284 (1982) 24-26
15. Olfson M., Marcus S.C., Tedeschi M., et al. Continuity of antidepressant treatment for adults with depression in the United States. Am J Psychiatry 163 1 (2006) 101-108
16. Bambauer K.Z., Adams A.S., Zhang F., Minkoff N., Grande A., Weisblatt R., et al. Physician alerts to increase antidepressant adherence - fax or fiction?. Arch Int Med 166 5 (2006) 498-504
17. Bultman D.C., and Svarstad B.L. Effects of physician communication style on client medication beliefs and adherence with antidepressant treatment. Patient Educ Couns 40 (2000) 173-185
18. Melfi C.A., Chawla A.J., Croghan T.W., Hanna M.P., Kennedy S., and Sredl K. The effects of adherence to antidepressant treatment guidelines on relapse and recurrence of depression. Arch Gen Psychiatr 55 (1998) 1128-1132
19. Peveler R., Grorge C., Kinmonth A., Campbell M., and Thompson C. Effect of antidepressant drug counseling and information leaflets on adherence to drug treatment in primary care: randomized controlled trial. BMJ 319 (1999) 612-615
20. Lin E., Von Korff M., Katon W., Bush T., Simon G.E., Walker E., et al. The role of the primary care physician in patients' therapy. Med Care 33 (1995) 67-74
21. Bultman D.C., and Svarstad B.L. Effects of pharmacist monitoring on patient satisfaction with antidepressant medication therapy. J Am Pharm Assoc 42 (2002) 36-43
22. Greenberg P.E., Stiglin L.E., Finkelstein S.N., and Berndt E.R. The economic burden of depression in 1990. J Clin Psychiatry 54 (1993) 405-418
23. Johnson D.A.W. Depression: treatment compliance in general practice. Acta Psychiat Scand 6 (1981) 447-453
24. Demyttenaere K., Enzlin P., Dewe W., Boulanger B., De Bie J., De Troyer W., et al. Compliance with antidepressants in a primary care setting, 2: the influence of gender and type of impairment. J Clin Psychiatry 62 Suppl. 22 (2001) 34-37
25. Tierney R., Melfi C.A., Signa W., and Croghan T.W. Antidepressant use and use patterns in naturalistic settings. Drug Benefit Trends 12 6 (2000) 7BH-12BH
26. Mullins C.D., Shaya F.T., Meng F.L., Wang J.L., and Harrison D. Persistence, switching, and discontinuation rates among patients receiving sertraline, paroxetine, and Citalopram. Pharmacotherapy 25 5 (2005) 660-667
27. Hansen D.G., Vach W., Rosholm J.-U., Søndergaard J., Gram L.F., and Kragstrup J. Early discontinuation of antidepressants in general practice: association with patient and prescriber characteristics. Fam Pract 21 (2004) 623-629
28. Montgomery S.A., Henry J., McDonald G., et al. Selective serotonin reuptake inhibitors: meta-analysis of discontinuation rates. Int Clin Psychopharmacol 9 (1994) 47-53
29. Anderson I.M., and Tomenson B.M. Treatment discontinuation with selective serotonin reuptake inhibitors compared with tricyclic antidepressants: a meta-analysis. Br Med J 310 (1995) 1433-1438
30. Barbui C., Hotopf M., Freemantle N., et al. Selective serotonin reuptake inhibitors versus tricyclic and heterocyclic antidepressants: comparison of drug adherence. Cochrane Database Syst Rev (2000) CD002791
31. Maddox J.C., Levi M., and Thompson C. The compliance with antidepressants in general practice. J Psy choparmacol 8 (1994) 48-53
32. Demyttenaere K., Enzlin K.P., Dewé W., Boulanger B., De Bie J., De Troyer W., et al. Compliance with antidepressants in a primary care setting, 1: beyond lack of efficacy and adverse events. J Clin Psychiatry 62 Suppl. 22 (2001) 30-33
33. Cochran S.D. Compliance with lithium regimens in the outpatient treatment of bipolar affective disorder. J Compliance Health Care 1 (1986) 153-170
34. Jamison K.R., and Akiskal H.S. Medication compliance in patients with bipolar disorder. Psychiatr Clin North Am 6 (1983) 175-192
35. Connelly C.E., Davenport Y.B., and Nurnberger J.I. Adherence to treatment regimen in a lithium carbonate clinic. Arch Gen Psychiatry 39 (1982) 585-592
36. Jamison K.R. Patient and physician attitudes toward lithium - relationship to compliance. Arch Gen Psychiatry 36 (1979) 866
37. Scott J., and Pope M. Self-reported adherence to treatment with mood stabilizers, plasma levels, and psychiatric hospitalization. Am J Psychiatry 159 (2002) 1927-1929
38. Colom F., Vieta E., Martinez-Aran A., Reinares M., Benabarre A., and Gasto C. Clinical factors associated with treatment non-compliance in euthymic bipolar patients. J Clin Psychiatry 61 8 (2000) 549-555
39. Johnson R.E., and McFarland B.H. Lithium use and discontinuation in a health maintenance organization. Am J Psychiatry 153 (1996) 993-1000
40. Keck P.E., McElroy S.L., Strakowski S.M., et al. Compliance with maintenance treatment in bipolar disorder. Psychopharmacol Bull 33 1 (1997) 87-91
41. Bowden C.L., Collins M.A., McElroy S.L., Calabrese J.R., Swann A.C., Weisler R.H., et al. Relationship of mania symptomatology to maintenance treatment response with divalproex, lithium, or placebo. Neuropsychopharmacology 30 (2005) 1932-1939
42. Sajatovic M., Valenstein M., Blow F.C., Ganoczy D., and Ignacio R.V. Treatment adherence with antipsychotic medications in bipolar disorder. Bipolar Disord 8 (2006) 232-241
43. Jamison K.R., Gerner R.H., and Goodwin F.K. Patient and physician attitudes toward lithium: relationship to compliance. Arch Gen Psychiatry 36 (1979) 866-869
44. Lacro J.P., Dunn L.B., Dolder C.R., Leckband S.G., and Jeste D.V. Prevalence of and risk factors for medication nonadherence in patients with schizophrenia: a comprehensive review of recent literature. J Clin Psychiatry 63 (2002) 892-909
45. Donohoe G., Owens N., O'Donnell C., Burke T., Moore L., Tobin A., et al. Predictors of compliance with neuroleptic medication among inpatients with schizophrenia: a discriminant function analysis. Eur Psychiatry 16 5 (2001) 293-298
46. Rijcken C.A.W., Tobi H., Vergouwen A.C.M., and de Jong-van den Berg L.T.W. Refill rate of antipsychotic drugs: an easy and inexpensive method to monitor patients' compliance by using computerised pharmacy data. Pharmacoepidemiol Drug Saf 13 (2004) 365-370
47. Vanelli M., Burstein P., and Cramer J. Refill patterns of atypical and conventional antipsychotic medications at a national retail pharmacy chain. Psychiatr Serv 52 (2001) 1248-1250
48. Hogman G., and Sandamas G. A question of choice (2000), National Schizophrenia Fellowship, London
49. Docherty JP, Grogg AL, Kozma C, et al. Antipsychotic maintenance in schizophrenia: partial compliance and clinical outcome. Presented at the annual meeting of the American College of Neuropsychopharmacology, San Juan, Puerto Rico; Dec 8-12, 2002.
50. McCombs J.S., Nichol M.B., Stimmel G.L., et al. Use patterns for antipsychotic medications in Medicaid patients with schizophrenia. J Clin Psychiatry 60 Suppl. 19 (1999) 5-11
51. Kang S.H., Kim H.S., Kim C.Y., and Hong J.P. Antipsychotic compliance and maintenance dosage in admitted patients with schizophrenia who had been followed up over 6 months. European Neuropsychopharmacology. J Eur Neuropsychopharmacol 15 Suppl. 3 (2005) S490
52. Purdon S.E., Jones B.D.W., Stip E., et al. Neuropsychological changes in early phase schizophrenia during 12 months treatment with olanzapine, risperidone or haloperidol. The Canadian Collaborative Group for research in schizophrenia. Arch Gen Psychiatry 154 (2000) 249-258
53. Tiihonen J., Walhbeck K., Lonnqvist J., Klaukka T., Ioannidis J.P., Volavka J., et al. Effectiveness of antipsychotic treatments in a nationwide cohort of patients in community care after first hospitalisation due to schizophrenia and schizoaffective disorder: observational follow-up study. BMJ 333 (2006) 224-227
54. Hodgson RE, Belgamwar R, Al-tawarah Y, MacKenzie G. The use of atypical antipsychotics in the treatment of schizophrenia in North Staffordshire. Human Psychopharmacology [in press].
55. Bitter I., Czobor P., Dossenbach M., et al. Effectiveness of clozapine, olanzapine, quetiapine, risperidone, and haloperidol monotherapy in reducing hostile and aggressive behavior in outpatients treated for schizophrenia: a prospective naturalistic study (IC-SOHO). Eur Psychiatry 20 5-6 (2005) 403-408
56. Lieberman J.A., Stroup T.S., McEvoy J.P., et al. Effectiveness of antipsychotic drugs in patients with chronic schizophrenia. N Engl J Med 353 12 (2005) 1209-1223
57. Rosenheck R., Cramer J., Xu W., et al. A comparison of clozapine and haloperidol in hospitalized patients with refractory schizophrenia: department of veterans affairs cooperative study group on clozapine in refractory schizophrenia. N Engl J Med 337 (1997) 809-815
58. Deci E.L., and Ryan R.M. The 'what' and 'why' of goal pursuits: human needs and the self-determination of behavior. Psychol Inq 11 (2000) 227-268
59. Williams G.C., Rodin G.C., Ryan R.M., et al. Autonomous regulation and long-term medication adherence in adult outpatients. Health Psychol 17 3 (1998) 269-276
60. Kennedy S., Goggin K., and Nollen N. Adherence to HIV medications: utility of the theory of self-determination. Cogn Ther Res 28 5 (2004) 611-628
61. Williams G.C., McGregor H.A., Zeldman A., Freedman Z.R., and Deci E.L. Testing a self-determination theory process model for promoting glycemic control through diabetes self-management. Health Psychol 23 1 (2004) 58-66
62. Demyttenaere K., Enzlin K.P., Dewé W., Boulanger B., De Bie J., De Troyer W., et al. Compliance with antidepressants in a primary care setting, 1: beyond lack of efficacy and adverse events. J Clin Psychiatry 62 Suppl. 22 (2001) 30-33
63. Col N., Fanale J., and Kronholm P. The role of medication noncompliance and drug reactions in hospitalizations of the elderly. Arch Intern Med 150 (1990) 841-845
64. Bull S.A., Hu X.H., Hunkeler E.M., et al. Discontinuation of use and switching of antidepressants - influence of patient-physician communication. JAMA 288 11 (2002) 1403-1409
65. Sirey J., Bruce M., Alexopoulos G., et al. Perceived stigma as a predictor of treatment discontinuation in young and older outpatients with depression. Am J Psychiatry 158 (2001) 479-481
66. Sirey J., Bruce M., Alexopoulos G., et al. Stigma as a barrier to recovery: perceived stigma and patient-rated severity of illness as predictors of antidepressant Drug adherence. Psychiatr Serv 52 (2001) 1615-1620
67. Aikens J.E., Kroenke K., Swindle R.W., and Eckert G.J. Nine-month predictors and outcomes of SSRI antidepressant continuation in primary care. Gen Hosp Psychiatry 27 4 (2005) 229-236
68. Ayalon L., Arean P.A., and Alvidrez J. Adherence to antidepressant medications in black and Latino elderly patients. Am J Geriatr Psychiatry 13 7 (2005) 572-580
69. Schumann C., Lenz G., Berghöfer A., et al. Non-adherence with long-term prophylaxis: a 6-year naturalistic follow-up study of affectively ill patients. Psychiatry Res 89 (1999) 247-257
70. Dharmendra M.S., and Eagles J.M. Factors associated with patients' knowledge of and attitudes towards treatment with lithium. J Affect Disorder 75 1 (2003) 29-33
71. Kleindienst N., and Greil W. Are illness concepts a powerful predictor of adherence to prophylactic treatment in bipolar disorder?. J Clin Psychiatry 65 (2004) 966-974
72. Gitlin M.J., Cochran S.D., and Jamison K.R. Maintenance lithium treatment: side effects and compliance. J Clin Psychiatry 50 (1989) 127-131
73. Maarbjerg K., Aagaard J., and Vestergaard P. Adherence to lithium prophylaxis, 1: clinical predictors and patient's reasons for nonadherence. Pharmacopsychiatry 21 (1988) 121-125
74. Awad A.G., and Voruganti L.N.P. New antipsychotics, compliance, quality of life, and subjective tolerability - are patients better off?. Can J Psychiatry 49 (2004) 297-302
75. Fakhouri W. Extent of distress caused by adverse experiences associated with antipsychotic treatment. Presented at the European College of Neuropsychopharmacology Congress, London, United Kingdom; Sept 21-25, 1999.
76. Weiden P.J., Mackell J.A., and McDonnell D.D. Obesity as a risk factor for antipsychotic noncompliance. Schizophr Res 66 1 (2004) 51-57
77. Cutler A.J. Sexual dysfunction and antipsychotic treatment. Psychoneuroendocrinology 28 Suppl. 1 (2003) 69-82
78. Lambert M., Conus P., Eide P., Mass R., Karow A., Moritz S., et al. Impact of present and past antipsychotic side-effects on attitude toward typical antipsychotic treatment and adherence. Eur Psychiatry 19 7 (2004) 415-422
79. Rettenbacher M.A., Hofer A., Eder U., Hummer M., Kemmler G., Weiss E.M., et al. Compliance in schizophrenia: psychopathology, side-effects, and patients' attitudes toward the illness and medication. J Clin Psychiatry 65 9 (2004) 1211-1218
80. Adewuya A.O., Ola B.A., Mosaku S.K., Fatoye F.O., and Eegunranti A.B. Attitude towards antipsychotics among out-patients with schizophrenia in Nigeria. Acta Psychiatrica Scandinavica 113 (2006) 207-211
81. Kozuki Y., and Froelicher E.S. Lack of awareness and nonadherence in schizophrenia. West J Nurs Res 25 1 (2003) 57-74
82. Rittmannsberger H., Pachinger L., Keppelmuller P., and Wancata J. Medication adherence among psychotic patients before admission to inpatient treatment. Psychiatr Serv 55 2 (2004) 174-179
83. Day J.C., Bentall R.P., Roberts C., Randall F., Rogers A., Cattell D., et al. Attitudes toward antipsychotic medication - the impact of clinical variables and relationships with health professionals. Arch Gen Psychiatry 62 7 (2005) 717-724
84. Elbogen E.B., Swanson J.W., Swartz M.S., and Van Dorn R. Medication nonadherence and substance abuse in psychotic disorders - impact of depressive symptoms and social stability. J Nerv Ment Dis 193 10 (2005) 673-679
85. Yen C.F., Chen C.S., Ko C.H., Yeh M.L., Yang S.J., Yen J.Y., et al. Relationships between insight and medication adherence in outpatients with schizophrenia and bipolar disorder: prospective study. Psychiatr Clin Neurosci 59 4 (2005) 403-409
86. Ashton A.K., Jamerson B.D., Weinstein W.L., and Wagoner C. Antidepressant-related adverse effects impacting treatment compliance: results of a patient survey. Curr Ther Res Clin Exp 66 2 (2005) 96-106
87. Maddigan S.L., Farris K.B., Keating N., Wiens C.A., and Johnson J.A. Predictors of older adults' capacity for medication management in a self-medication program: a retrospective chart review. J Aging Health 15 2 (2003) 332-352
88. Ozmen E., Ogel K., Aker T., Sagduyu A., Tamar D., and Boratav C. Public opinions and beliefs about the treatment of depression in urban Turkey. Soc Psychiatry Psychiatr Epidemiol 40 11 (2005) 869-876
89. Paykel E.S., Hart D., and Priest R. Changes in public attitudes to depression during the defeat depression campaign. Br J Psychiatry 173 (1998) 519-522
90. Jorm A.F., Christensen H., and Griffiths K.M. Belief in the harmfulness of antidepressants: results from a national survey of the Australian public. J Affect Disorder 88 1 (2005) 47-53
91. Althaus D., Stefanek J., Hasford J., and Hegerl U. Knowledge and attitudes of the general population towards symptoms, causes, and treatment of depressive disorders. Nervenarzt 73 7 (2002) 659-664
92. van Schaik D.J.F., Klijn A.F.J., van Hout H.P.J., van Marwijk H.W.J., Beekman A.T.F., de Haan M., et al. Patients' preferences in the treatment of depressive disorder in primary care. Gen Hosp Psychiatry 26 3 (2004) 184-189
93. Pound P., Britten N., Morgan M., Yardley L., Pope C., ker-White G., et al. Resisting medicines: a synthesis of qualitative studies of medicine taking. Soc Sci Med 61 1 (2005) 133-155
94. Viller F., Guillemin F., Briancon S., Moum T., Suurmeijer T., and van den H.W. Compliance to drug treatment of patients with rheumatoid arthritis: a 3 year longitudinal study. J Rheumatol 26 (1999) 2114-2122
95. Marder S.R. Overview of partial compliance. J Clin Psychiatry 64 Suppl. 16 (2003) 3-9
96. Aikens J.E., Nease Jr. D.E., Nau D.P., Klinkman M.S., and Schwenk T.L. Adherence to maintenance-phase antidepressant medication as a function of patient beliefs about medication. Ann Fam Med 3 1 (2005) 23-30
97. Bull S.A., Hunkeler E.M., Lee J.Y., Rowland C.R., Williamson T.E., Schwab J.R., et al. Discontinuing or switching selective serotonin-reuptake inhibitors. Annal Pharmacother 36 4 (2002) 578-584
98. Hamann J., Leucht S., and Kissling W. Shared decision making in psychiatry. Acta Psychiatr Scand 107 6 (2003) 403-409
99. Garfield S., Francis S.A., and Smith F.J. Building concordant relationships with patients starting antidepressant medication. Patient Educ Couns 55 2 (2004) 241-246
100. Arora N.K., and McHorney C.A. Patient preferences for medical decision making - who really wants to participate?. Med Care 38 3 (2000) 335-341
101. Maidment R., Livingston G., and Katona C. 'Just keep taking the tablets': adherence to antidepressant treatment in older people in primary care. Int J Geriatr Psychiatry 17 8 (2002) 752-757
102. Sleath B., Rubin R.H., and Huston S.A. Hispanic ethnicity, physician-patient communication, and antidepressant adherence. Compr Psychiatry 44 3 (2003) 198-204
103. Marder S.R. Subjective experiences on antipsychotic medications: synthesis and conclusions. Acta Psychiatrica Scandinavica 111 Suppl. 427 (2005) 43-46
104. Gray R., Rofail D., Allen J., et al. A survey of patient satisfaction with and subjective experiences of treatment with antipsychotic medication. J Adv Nurs 52 1 (2005) 31-37
105. Maidment R., Livingston G., and Katona C. 'Just keep taking the tablets': adherence to antidepressant treatment in older people in primary care. Int J Geriatr Psychiatry 17 8 (2002) 752-757
106. Rokke P.D., Tomhave J.A., and Jocic Z. The role of client choice and target selection in self-management therapy for depression in older adults. Psychol Aging 14 1 (1999) 155-169
107. Peveler R, Kendrick T, Buxton M, Longworth L, Baldwin D, Moore M, et al. A randomised controlled trial to compare the cost-effectiveness of tricyclic antidepressants, selective serotonin reuptake inhibitors and lofepramine source: Health Technol Assess 9 (16): III-+ MAY 2005.
108. King M., Nazareth I., Lampe F., Bower P., Chandler M., Morou M., et al. Impact of participant and physician intervention preferences on randomized trials - a systematic review. JAMA 293 9 (2005) 1089-1099
109. Hevey D., Smith M., and McGee H.M. Self-efficacy and health behaviour: a review. Irish J Psychol 19 2-3 (1998) 248-273
110. Flynn K.E., Smith M.A., and Vanness D. A typology of preferences for participation in healthcare decision making. Soc Sci Med 63 5 (2006) 1158-1169
111. Ford S., Schofield T., and Hope T. Are patients' decision-making preferences being met?. Health Expect 6 1 (2003) 72-80
112. Stevenson F.A., Barry C.A., Britten N., et al. Doctor-patient communication about drugs: the evidence for shared decision making. Soc Sci Med 50 (2000) 829-840
113. Elwyn G., Edwards A., Wensing M., Hibbs R., Wilkinson C., and Grol R. Shared decision making observed in clinical practice: visual displays communication sequence and patterns. J Eval Clin Pract 7 2 (2001) 211-221
114. Gattellari M., Voigt K.J., Butow P.N., and Tattersall H.N. When the treatment goal is not cure: are cancer patients equipped to make informed decisions?. J Clin Oncol 20 2 (2002) 503-513
115. Braddock C.H., Edwards A.K., Hasenberg N.M., Laidley T.L., and Levinson W. Informed decision making in outpatient practice, time to get back to basics. JAMA 282 24 (1999) 2313-2320
116. McGrath J.M. Physicians perspectives on communicating prescription drug information. Qual Health Res 9 (1999) 731-745
117. Makoul G., Arntson P., and Schofield T. Health promotion in primary-care - physician-patient communication and decision-making about prescription medications. Soc Sci Med 41 (1995) 1241-1254
118. Sleath B., Chewning B., Svarstad B., and Roter D. Patient expression of complaints and adherence problems with medications during chronic disease medical visits. J Soc Admin Pharm 17 (2000) 71-80
119. Stevenson F.A., Cox K., Britten N., and Dundar Y. A systematic review of the research on communication between patients and health care professionals about medicines: the consequences for concordance. Health Expect 7 (2004) 235-245